CRIS - Curis Inc logo

CRIS

Curis Inc

Curis Inc is a biotechnology company focused on developing drug candidates for cancer treatment. Its pipeline includes drugs for various cancers, with collaborations for commercializing Erivedge and advancements in immuno-oncology and precision oncology.

โš•๏ธ Healthcare NASDAQ Listed 2000 $ USD
$1,000 invested 20 years ago โ†’$1today

Score Overview

1 Year
Score
Net Growth-179.15%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-25.20%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.4
Net Growth53.42%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-33.67%
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Score
Net Growth64.96%
Net Trend70%
Net Income Consistency
Rev Growth-6.16%
Rev Trend40%
Revenue Consistency
20 Years
Score2.4
Net Growth-139.71%
Net Trend55%
Net Income Consistency
Rev Growth-52.71%
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth93.96%
Net Trend54%
Net Income Consistency
Rev Growth7x
Rev Trend46%
Revenue Consistency

See the full market ranking โ†’

Curis Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 10M to $ 9M and net income went from -$ 29M to -$ 7M. Revenue increased in 1 of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 7M to $ 9M and net income went from -$ 58M to -$ 7M. Revenue increased in 4 of those 10 years; net income in 7.

Curis Inc currently holds a 20-year HDB Score of 2.4 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.67โ€”
1 Year2025-08-12
$ 33.00-94.94%
5 Years2021-08-12
$ 3.1K-99.95%
10 Years2016-08-12
$ 3.46K-99.95%
20 Years2006-08-11
$ 1.9K-99.91%
All Time2000-08-01
$ 48.75K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 7M-$ 21M$ 15M
2025$ 9M-$ 7M$ 5M
2024$ 10M-$ 43M$ 19M
2023$ 10M-$ 47M$ 56M
2022$ 10M-$ 60M$ 85M
2021$ 10M-$ 45M$ 115M
2020$ 10M-$ 29M$ 168M
2019$ 10M-$ 32M$ 20M
2018$ 10M-$ 32M$ 24M
2017$ 9M-$ 53M$ 60M
2016$ 7M-$ 60M$ 44M
2015$ 7M-$ 58M$ 82M
2014$ 9M-$ 18M$ 50M
2013$ 15M-$ 12M$ 68M
2012$ 16M-$ 16M$ 58M
2011$ 14M-$ 9M$ 235.91K
2010$ 15M-$ 4M$ 40M
2009$ 8M-$ 9M$ 25M
2008$ 8M-$ 12M$ 28M
2007$ 16M-$ 6M$ 41M
2006$ 14M-$ 8M$ 36M
2005$ 6M-$ 14M$ 44M
2004$ 4M-$ 13M$ 49M
2003$ 11M-$ 11M$ 35M
2002$ 18M-$ 82M$ 40M
2001$ 1M-$ 81M$ 52M
IPO2000$ 997.08K-$ 350M$ 75M

Explore beyond CRIS

You're looking at Curis Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies